Glenn Smits
AeroLeads people directory · profile

Glenn Smits Email & Phone Number

World-wide and World-class Preclinical Research for the Med Tech Industry at NAMSA
Location: New Richmond, Wisconsin, United States 15 work roles 4 schools
1 work email found @cancergenetics.com LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email g****@cancergenetics.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
World-wide and World-class Preclinical Research for the Med Tech Industry
Location
New Richmond, Wisconsin, United States

Who is Glenn Smits? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Glenn Smits is listed as World-wide and World-class Preclinical Research for the Med Tech Industry at NAMSA, based in New Richmond, Wisconsin, United States. AeroLeads shows a work email signal at cancergenetics.com and a matched LinkedIn profile for Glenn Smits.

Glenn Smits previously worked as Vice President of Global Preclinical Research at Namsa and Founder at "3S Llc" (Smits Scientific Solutions Llc). Glenn Smits holds Phd, Pharmacology from Saint Louis University.

Company email context

Email format at NAMSA

This section adds company-level context without repeating Glenn Smits's masked contact details.

{first_initial}{last}@cancergenetics.com
86% confidence

AeroLeads found 1 current-domain work email signal for Glenn Smits. Compare company email patterns before reaching out.

Profile bio

About Glenn Smits

I am a team-oriented leader, with solid scientific credentials and experience, covering a wide range of therapeutic areas and treatment modalities. I have established research, program, and business plans and budgets; built and managed effective networks of KOLs and clients; managed in matrix-aligned organizations, and advanced programs leveraging both authority and influence. My career has spanned large pharmaceutical companies, biotech companies, and contract research organizations, with positions ranging from scientific to senior management. My scientific focus has been primarily in cardio/renal/metabolic disease areas with additional extensive experience in oncology, immuno-oncology, fibrosis, immunological disorders, and neurological diseases. I have extensive experience in GLP-compliant safety assessment across geographies. I have extensive network of connections within the CRO industry, especially pre/non-clinical focused CROs.

Listed skills include Drug Discovery, Pharmacology, Clinical Development, Biotechnology, and 46 others.

Current workplace

Glenn Smits's current company

Company context helps verify the profile and gives searchers a useful next step.

NAMSA
Namsa
World-wide and World-class Preclinical Research for the Med Tech Industry
AeroLeads page
15 roles · 40 years

Glenn Smits work experience

A career timeline built from the work history available for this profile.

Vice President Of Global Preclinical Research

Current

Toledo, Oh, Us

Provides leadership and strategic direction for the Global Preclinical Interventional and Surgical Research (ISR) program for NAMSA, at our sites in Minneapolis MN, Northwood OH, Diest Belgium, and Lyon France.

Apr 2024 - Present

Founder

Current
"3S Llc" (Smits Scientific Solutions Llc)
Jun 2022 - Present

Vice President Of Drug Safety And Toxicology

Cincinnati, Ohio, Us

Jul 2022 - Apr 2024

(Vivopharm Business Unit) Senior Vice President, Discovery And Early Development

Cherry Hill, Nj, Us

Aug 2017 - Feb 2022

Vice President, Pharmacology And Toxicology

Hershey, Pa, Us

Apr 2015 - Aug 2017

Director, Business Development And Marketing

Hershey, Pa, Us

May 2013 - Apr 2015

Scientific Writer

San Francisco, California, Us

As Scientific Writer, I provide writing services to Clinovo's clients, including clinical evaluation plans and reports for regulatory submission, scientific/clinical manuscripts for submission to peer-reviewed journals, preparation of presentations (powerpoint slide-decks, posters, etc.), and others.

Apr 2013 - Dec 2015

Vice President And General Manager, Discovery Sciences

Mattawan, Mi, Us

The Vice President of the Discovery Center is responsible for the strategic direction, growth, and performance of the Discovery Center of MPI Research, which includes the following Product Lines: ADME (Absorption, Distribution, Metabolism, and Excretion), Pharmacokinetics (PK), Surgery and Experimental Therapeutics (ET). The Senior Directors/Directors of ADME, PK, Surgery, and Experimental Therapeutics (as well as other Departments, such as Molecular Imaging, Cell & Molecular Biology, and Product Lines that may comprise the Discovery Center) report to the Vice President of the Discovery Center.

Sep 2008 - Sep 2012

Founder

Scv Consultants

Provide consulting services to biotech, pharma, and medical device companies.

Nov 2007 - Sep 2008

Scientific Director

Wilmington, Massachusetts, Us

Direct and oversee the execution and quality of scientific research within the site. Assure all scientific processes and practices meet or exceed client needs. Direct the development, interpretation, implementation and achievement of short- and long-range scientific objectives for the site. Ensure program integration and optimization of group function and business unit. Recommend and implement techniques and practices to improve productivity, increase efficiencies, cut costs, take advantage of opportunities, and maintain state-of-the-art practices.

2002 - 2006 ~4 yrs

Associate Director

Genome Therapeutics

Establish and build a pharmacology and pharmacokinetics team to support internal drug discovery projects. Coordinate and manage external contract research studies and supervise internal laboratory and staff. Internal capabilities include bioanalytical capabilities (LC/MS/MS, ELSD, UV) and in vitro drug metabolism and toxicity.

2001 - 2002 ~1 yr

Senior Scientist

Cambridge, Ma, Us

Pharmacology for adenosine project(s). Serve on Adentri Program Team, Adentri Strategy Team, Adentri Clinical Development Plan committee, and direct the Adentri Research Team. Recruited and built capabilities; from cloning and expression, radioligand binding, in vitro assays, in vivo pharmacokinetics/pharmacodynamics and safety assays and in vivo efficacy models. Plan, write and review regulatory submissions (Pre-IND, IND, NDA). Establish rodent models of fibrosis, congestive heart failure, renal function, hemodynamic profiling, isolated heart and vessels, thrombosis and other models in-house and manage collaborations with external investigators. Provide general pharmacology support to other programs at Biogen. Initiate novel drug discovery programs. Serve on Scientific Review Committee and Scientist Promotion Committee. Directed efforts of Molecular Pharmacology group, PK/PD group and Fibrosis Pharmacology group (each group consisting of PhD Scientist and 2 to 4 associates).

1998 - 2001 ~3 yrs

Cardiology Senior Research Associate

Browns Mills, New Jersey, Us

Independent research pertaining to physiology and patho-physiology of myocardial ischemia/reperfusion injury and vascular proliferation (restenosis). Areas of particular interest are: role of immediate-early gene (EGR-1) expression in vascular proliferation and the regulation of transcription of these genes; effects of adenosine receptor activation on ischemia/reperfusion injury; role of leukocytes and free radical generation in reperfusion injury and stimulation of cardiomyocyte apoptosis; cardio- and vasculo-protective effects of heat shock protein induction; mechanisms of ischemic preconditioning; mechanisms of myocardial stunning.

1996 - 1998 ~2 yrs

Research Scientist

In vivo pharmacology, primarily ischemia/reperfusion injury and hemodynamics. Developed concept of utility of a mixed A1/A2a Adenosine agonist as treatment of reperfusion injury; designed, conducted, and managed non-clinical studies in acute ischemia/reperfusion injury models; assembled justification for clinical development of the mixed A1/A2a adenosine agonist AMP579; contributed non-clinical pharmacology section of AMP579 IND. Establish rat and pig models of myocardial ischemia/reperfusion injury and rat model of acute renal failure. Perform balloon injury model in porcine coronary arteries. Instrumentation of rat and dog for telemetry measurement of arterial pressure and locomotor activity. Wrote sections of IND applications. Supervise research associates.

1991 - 1996 ~5 yrs

Research Associate

Us

In vivo pharmacology of vasoactive agents and antagonists. In vivo experimentation to support ongoing research projects of Cardiovascular Disease team. Develop models of hypertension in rat, dog and pig. Investigation of roles of angiotensin, bradykinin and atrial natriuretic peptide in hypertension, heart failure and myocardial ischemia and effects on renal function. Managed in vivo team for Angiotensin II antagonist project. Initiated project for imidazoline receptor agonists. Several projects resulted in clinical evaluation (atrial natriuretic peptides and Angiotensin II receptor antagonist). Contributed to IND reports. Supervise research associate.

1987 - 1991 ~4 yrs
4 education records

Glenn Smits education

Phd, Pharmacology

Saint Louis University

Ms, Physiology

Medical College Of Wisconsin

Bs, Biology

Marquette University

Education record

Depere High
FAQ

Frequently asked questions about Glenn Smits

Quick answers generated from the profile data available on this page.

What company does Glenn Smits work for?

Glenn Smits works for NAMSA.

What is Glenn Smits's role at NAMSA?

Glenn Smits is listed as World-wide and World-class Preclinical Research for the Med Tech Industry at NAMSA.

What is Glenn Smits's email address?

AeroLeads has found 1 work email signal at @cancergenetics.com for Glenn Smits at NAMSA.

Where is Glenn Smits based?

Glenn Smits is based in New Richmond, Wisconsin, United States while working with NAMSA.

What companies has Glenn Smits worked for?

Glenn Smits has worked for Namsa, "3S Llc" (Smits Scientific Solutions Llc), Orange Grove Bio, Vyant Bio, and Vivopharm Llc.

How can I contact Glenn Smits?

You can use AeroLeads to view verified contact signals for Glenn Smits at NAMSA, including work email, phone, and LinkedIn data when available.

What schools did Glenn Smits attend?

Glenn Smits holds Phd, Pharmacology from Saint Louis University.

What skills is Glenn Smits known for?

Glenn Smits is listed with skills including Drug Discovery, Pharmacology, Clinical Development, Biotechnology, Cro, In Vivo, Glp, and Drug Development.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.